Editor's key points † Postoperative pulmonary complications are common after lung resection surgery. † In this study, the use of continuous positive airway pressure (CPAP) for 6 h after surgery improved oxygenation at 24 h. † However, postoperative CPAP had no effect on clinical outcomes. † The optimum duration of CPAP after lung resection remains unclear.
the role of atelectasis in postoperative respiratory dysfunction has been recognized. Decreased lung compliance and functional residual capacity (FRC) is manifest clinically by impaired gas exchange, the development of pneumonia or acute lung injury in some cases. 6 -9 The immediate postoperative period is considered a key period in the treatment or prophylaxis of atelectasis, because the residual effects of anaesthesia combined with reduced muscle strength prevents deep inspiration and expansion of collapsed alveolar units. Therefore, the lung recruitment manoeuvres proposed to prevent or treat atelectasis, include taking deep breaths (sighs), incentive spirometry, chest physiotherapy, and non-invasive ventilation (NIV). Furthermore, atelectasis may predispose a patient to pneumonia. 10 Although lung recruitment manoeuvres are not universally considered useful, they are considered to be helpful for patients at increased risk of developing PPC. 11 -13 Several studies have investigated the usefulness of NIV in the prevention of PPC after thoracic surgery, although most were carried out with mechanical ventilators using biphasic positive airway pressure (BiPAP). 14 -16 Continuous positive airway pressure (CPAP) is a simple way to provide continuous positive pressure in the airway throughout the respiratory cycle without the use of complex equipment, which is usually available only in intensive care units (ICUs). The application of CPAPafter surgery can help open collapsed alveolar units, prevent alveolar closure or both, thus increasing postoperative FRC and forced vital capacity, and is associated with decreased respiratory workload and improved gas exchange.
Although CPAP appears to be more effective than routine chest physiotherapy, 18 its benefits have not been clearly demonstrated. CPAP is widely accepted for the management of patients with respiratory failure, but there are few data on its use to prevent PCC after LRS. The aims of our study were to assess the effect of prophylactic CPAP on the Pa O 2 /FI O 2 ratio on the day after surgery in patients undergoing LRS and to identify those patients in whom its preventive effect is greatest.
Methods

Patients and ethics
This study was approved by the Clinical Research Ethics Committee of Hospital General Universitario Gregorio Marañ ó n. All patients signed an informed consent detailing the content of our research. The study was performed following the principles of the Declaration of Helsinki.
We included 110 consecutive patients undergoing pulmonary resection by lateral thoracotomy between April 2011 and May 2012. The primary outcome of the study was the Pa O 2 /FI O 2 ratio the morning after surgery. The exclusion criteria were: a diagnosis of obstructive sleep apnoea syndrome or any other process that required non-invasive mechanical ventilation before surgery, important bullous emphysema detected on preoperative computed tomography, bronchopleural fistula suspected on admission to the post-anaesthesia care unit (PACU), facial problems, a history of intolerance to CPAP masks, or impossibility of extubation within 4 h of leaving the operating theatre.
Intervention
All patients underwent surgery performed by one of the four thoracic surgeons and received similar anaesthetic management according to the standard practice of our hospital. This included postoperative local anaesthesia with 0.5% bupivacaine administered through a catheter placed in the paravertebral ipsilateral space (T5-T6) close to the site of the procedure. We used standardized protective ventilation throughout the procedure with a tidal volume of 5-6 ml kg 21 , respiratory rate of 12-14 bpm, and a positive end-expiratory pressure of 5 cm H 2 O. Three recruitment manoeuvres as described by Tusman and colleagues 19 were made 10-15 min after tracheal intubation, 5 min after one-lung ventilation, and when we restarted two-lung ventilation. Tracheal extubation was performed in the operating theatre after reversal of neuromuscular block, before transfer to their hospital bed in a semi-seated position. All patients were transferred to the PACU with supplemental oxygen (FI O 2 = 0.35-0.5) delivered through a Venturi facemask. Sp O 2 was monitored during transport and maintained .90%.
On arrival in the PACU, patients were assigned on a 1:1 ratio to one of the two groups (Venturi or CPAP) according to computer-generated randomization codes. The codes had been produced before recruiting the first participant and concealed in sealed envelopes each with a consecutive number written on the outside. The envelopes with the codes were kept in a locked cupboard and provided to the anaesthesiologist responsible for the care during the stay in the PACU by one sub-investigator not involved in attending patients. Only two sub-investigators had direct access to the key contained in sealed envelopes. All participants and PACU personnel were blinded to the allocation codes. Venturi group patients received the standard treatment used in our institution; supplemental oxygen was provided through the Venturi mask (adjustable Venturi oxygen mask, Intersurgical w Madrid, Spain). Patients in the CPAP group received CPAP via a Boussignac facial mask (Vygon w Valencia, Spain) that was adjusted to maintain a pressure of 5-7 cm H 2 O continuously for the following 6 h. The flow of both the oxygen meter and the air meter was adjusted to reach these pressure levels. After this period, CPAP patients received the same oxygen input as the other group. FI O 2 allowing an Sp O 2 .90% was used in both groups.
Measurements
Patient characteristics and surgical data were obtained from the patients' medical records. All patients underwent spirometry and a CO diffusion test (Masterscreen-PFT, Viasys, Hochberg, Germany) as part of routine preoperative evaluation.
In the PACU, we continuously measured heart rate (HR), arterial blood pressure (BP) from the radial artery, and Sp O 2 . Blood gases were determined on arrival at the PACU, 7 h later, and 24 h later via a sample of arterial blood taken through a radial artery catheter. The FI O 2 used at that time was recorded. The sample was analysed using GEM 4000 (Instrumentation Laboratory, Lexington, MA, USA). FI O 2 during use of the Venturi mask was determined according to the manufacturer's recommendations and set using the rotating attachment. We used a flow rate of 6 litre min 21 50%. In the CPAP group, we used a flow rate (air and oxygen) to reach a pressure of 5-7 cm H 2 O, and FI O 2 was calculated based on the ratio of litres delivered by the air flow meter and oxygen according to the formula: litres of oxygen + (litres of air × 0.21)/total amount of litres provided by both flow meters. The criteria for discharge from the PACU were haemodynamic stability, Sp O 2 .90% with FI O 2 ,0.4, absence of clinical signs of respiratory distress, full consciousness, and sufficient diuresis (.0.3 ml kg h 21 ). Patients were discharged to the ward the following morning by the attending physician of the PACU, who had not dealt with the patient the day before and therefore did not know to which group the patient had been assigned. The criteria for readmission to the PACU were those commonly used in our institution, namely decreased level of consciousness, haemodynamic instability (SBP ,90 mm Hg; or HR ,40 bpm or .120 bpm), or respiratory problems (breathing rate ,8 or .25 rpm, Sp O 2 ,90% with FI O 2 ≥0.5). The indication for reintubation was consistent with the usual criteria for this unit (Pa O 2 ,8 kPa or Sp O 2 ,90% with FI O 2 .0.5 or respiratory acidosis or respiratory rate .25 bpm). All patients underwent at least three chest radiographs: one on admission to the PACU, another 24 h later, and a third at discharge. Depending on the clinical course, further radiographs were ordered by thoracic surgeons when considered appropriate for management during postoperative hospital stay. All chest radiographs ordered during the postoperative period were evaluated by a single pulmonologist, who was unaware of the postoperative clinical course and of the treatment group to which the patient had been assigned. The thoracic surgeons in charge of evaluating the postoperative course were also blind to the group.
Secondary outcome variables
The incidence of atelectasis, pneumonia or both was recorded as a secondary variable. Atelectasis was evaluated using the scale of Wisconsin. 20 Pneumonia was diagnosed based on the criteria of Garner and colleagues. 21 The remaining variables studied were the presence of a persistent air leak, re-intubation, and readmission to the ICU after being discharged to the ward, and durations of PACU and hospital stay.
Respiratory risk stratification
All patients were assessed based on the respiratory risk classification of Arozullah and colleagues, 22 
Statistical analysis
The study was designed to include 110 patients to demonstrate a difference of more than 6 points in the Pa O 2 /FI O 2 ratio the morning after surgery between the two groups with a 5% risk of type I error and power of 80% and an expected population standard deviation of 11 points derived from previous measurements in our PACU. Because values were normally distributed, the results are expressed as mean (SD). We also performed a multiple comparison test by repeated-measures ANOVA. Continuous variables were compared using an unpaired t-test. Categorical variables were compared using the x 2 test, or the Fisher's exact test if the value of any cell was ,5. Statistical significance was set at P,0.05. The statistical analysis was performed using SPSS statistical software (version 15.0, Hispanoportuguesa SPSS, Madrid, Spain).
Results
Fifty-five patients were included in each group (Fig. 1) . No differences were found between the patients in preoperative characteristics or between the groups in average duration of surgery, unilateral ventilation time, type of surgical resection, or side of surgery (Table 1 ). All patients included in the study were extubated in the operating theatre at the end of the intervention. Arterial blood gases and the haemodynamic variables analysed (HR and BP) showed no significant differences within 15 min after admission to the PACU or within 7 h (in the CPAP group immediately after CPAP was removed). However, the day after surgery, patients in the CPAP group showed a significantly higher Pa O 2 /FI O 2 index than those in the Venturi group (P¼0.031) ( Table 2) .
Two patients in the CPAP group refused treatment in the first half hour of application of the mask: one because of the sensation of suffocation and the other because of pain in the area where the mask made contact with the skin of the face. These symptoms disappeared immediately after application of the Venturi mask.
No significant differences were observed between the groups in postoperative complications (Table 3 ). Chest radiographs revealed no differences between the groups. Postoperative course was similar in both groups. Only three of the treated patients (2.6%) required readmission to the ICU. In two cases, this was because of surgical problems (bronchopleural fistula and prolonged air leak, one in each group); in the other, the patient (CPAP group) was readmitted to the ICU for acute lung injury and died of multiorgan failure a week later. When we stratified patients based on respiratory risk score, we noted that in those with a lower risk, the use of CPAP did not improve Pa O 2 /FI O 2 at 24 h compared with those of the Venturi group. On the contrary, in the other two groups (intermediate or high respiratory risk), we observed a significant improvement in gas exchange in patients from the CPAP group compared with those of the Venturi group (Fig. 2) . In accordance with the Arozullah classification, patients with a significantly lower respiratory risk had a significantly lower incidence of pneumonia/atelectasis than patients in the intermediate and high-risk groups (P,0.05). However, we did not detect significant differences between the CPAP or Venturi groups in the incidence of pneumonia/atelectasis for each degree respiratory risk.
Discussion
We found that prophylactic postoperative CPAP administered to patients with a Boussignac mask (5 -7 cm H 2 O) during the first 6 h after LRS improved gas exchange at 24 h compared with patients receiving oxygen therapy via a Venturi mask.
Given the high incidence of atelectasis caused by the anaesthetic technique (a collapsed lung for longer than 1 h and the other under compression by the pressure of the abdominal viscera, mediastinum, and rollers) in patients undergoing LRS and the special characteristics of these patients (high prevalence of smokers and chronic obstructive pulmonary disease [COPD]), prophylactic measures to reduce PPCs have been proposed. 23 24 Continuous application of air pressure improves FRC and prevents airway collapse, thus reducing respiratory effort. CPAP has been used successfully in two studies for the treatment of respiratory failure in both surgical and non-surgical patients. 25 26 However, the authors of these studies do not clarify the role of CPAP in the postoperative prophylaxis of PPCs. In patients undergoing bariatric surgery, the beneficial effects observed were probably because of the ability of CPAP to prevent collapse of the upper airway, which would add to the potential effects on the lower respiratory tract. 27 -29 Although both CPAP and BiPAP are considered methods of lung expansion, the advantage offered by CPAP is its ease of use, and that it can be used in parts of the hospital other than the ICU. The prophylactic use of CPAP in patients undergoing LRS has received little attention. Many previous studies on the prophylactic effect of NIV in LRS were performed with BiPAP 14 -16 and generally showed good results in terms of improved lung function and decreased PPCs; however, most studies either had small samples or were not prospective randomized or controlled trials. Stock and colleagues studied the effect of prophylactic CPAP on an uninterrupted postoperative period of 4 h in nine patients undergoing sternotomy and observed a temporary improvement in FRC that lasted ,10 min after the withdrawal of CPAP. 30 Another study, also in a small sample (30 patients), compared the effects of CPAP on the control group in LRS, and, although no differences were detected between the groups, an improvement in arterial oxygenation and FVC was observed between the first and seventh days after surgery only in the CPAP group. 31 In our study, we observed that the effects on gas exchange were evident the morning after surgery in the CPAP group compared with patients in the Venturi group. No differences were observed between the groups at 7 h after surgery, possibly because of a methodological error: in the CPAP group, the blood gas analysis was stopped at the end of CPAP, and we calculated FI O 2 based on the proportion of air and oxygen flow. However, FI O 2 could be overestimated when the patient has both a higher breathing rate and a higher tidal volume. 32 The lack of differences between the groups at 7 h could also be because of the lung effects of CPAP. Unlike high-flow systems (e.g. Venturi), CPAP decreases respiratory effort and muscle fatigue. Therefore, patients in the Venturi group may have had more respiratory muscular fatigue during the 12 h after surgery in the PACU with decreasing ventilator function, seen as a deteriorating Pa O 2 /FI O 2 .
We did not find that use of CPAP was associated with better radiological assessment of patients in the Venturi group. Although chest radiography is the standard method in most hospitals for determining the presence of atelectasis and pneumonia, it is not very accurate or sensitive when assessing atelectasis (especially in bedridden patients), as detection is possible only when large areas of lung parenchyma are involved. The absence of differences between the groups may be because micro-atelectasis is poorly visible on the chest radiograph, even though this condition leads to a decrease in the Pa O 2 /FI O 2 ratio. Moreover, the Pa O 2 /FI O 2 ratio is one of the most commonly used laboratory tests in the assessment of the respiratory status of patients before discharge to the ward. Therefore, we thought that analysis of this ratio would be more sensitive when evaluating the effectiveness of CPAP. The higher Pa O 2 /FI O 2 ratios observed in the CPAP group than that in the Venturi group were probably because of the existence of fewer areas affected by micro-atelectasis in the CPAP group. Surprisingly, we found no studies evaluating the utility of prophylactic postoperative NIV based on respiratory risk. We believe that the usefulness of any manoeuvre to improve postoperative respiratory function will largelydepend on the patient's preoperative condition and respiratory risk associated with the surgical procedure. Respiratory risk attributable to surgery was similar in all our patients, although preoperative status was not. We observed that, in patients in whom CPAP was not used, the Pa O 2 /FI O 2 ratio decreased with the increasing respiratory risk, whereas patients in the CPAP group had similar Pa O 2 /FI O 2 values, regardless of their respiratory risk score. In other words, the CPAP use had more clinical relevance in patients with higher respiratory risk. We therefore believe that the prophylactic use of CPAP in LRS should be reserved for those patients.
There are some limitations to our study. First, our original study design was based on pressures of 5 -7 cm H 2 O, because higher pressures may affect surgical sutures or increase air leak, although there is insufficient evidence to determine the optimal CPAP pressure. In general, we recommend pressures of 7-10 cm H 2 O. 33 One study of 10 patients undergoing cardiac and thoracic surgery showed that the effect on gas exchange of a pressure of 10 cm H 2 O was greater than that of a pressure of 5 cm H 2 O with no haemodynamic differences. 34 Another study reported that pressure of 5 cm H 2 O seemed to cause little increase in pulmonary ventilation in COPD patients, although CPAP pressures (10 -5 cm H 2 O) increased emphysematous areas in the CT scan. 35 We decided to use pressure of Secondly, there is not enough evidence on both the duration and the optimum time to apply CPAP. Some authors have proposed applying it discontinuously several times a day and for several days after the postoperative course. 33 We believe CPAP would be more useful during the first hours after surgery, because patients remain under the residual effects of anaesthesia. Consequently, cooperation with respiratory physiotherapy will be poorer than in the days after surgery. The optimum time would probably be immediately after extubation. 27 When we designed the study, we sought a simple method that would allow us to apply the simplest possible lung expansion manoeuvre; therefore, we thought that transferring the patient to the PACU with CPAP, in the absence of clear evidence of greater benefits, represented an effort that would reduce the applicability of the procedure. Thirdly, inability of patients to tolerate these devices can be a barrier to use. In order to make CPAP more tolerable, its use has been proposed for short and repeated periods (e.g. 15 min every hour). However, we believe that if we had applied it intermittently during the first 24 h, we would have probably disrupted the patient's rest several times during the night stay in the PACU.
Finally, the sample size was chosen to detect a difference in Pa O 2 /FI O 2 ratio .10% between groups and it may not be clinically very relevant. However, to our knowledge, this is one of the larger studies that have investigated the prophylactic use of postoperative CPAP.
In conclusion, the prophylactic use of the Boussignac mask with CPAP of 5-7 cm H 2 O immediately after surgery improves the Pa O 2 /FI O 2 ratio at 24 h after LRS compared with the Venturi mask, but not earlier. This effect was more evident in surgical patients who previously presented a higher risk for respiratory complications.
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